deltatrials
Recruiting OBSERVATIONAL NCT05227924

Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty

Sponsor: Dedienne Sante S.A.S.

Updated 8 times since 2022 Last updated: Aug 26, 2024 Started: Sep 21, 2021 Primary completion: Sep 30, 2034 Completion: Sep 30, 2034
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Avascular Necrosis of the Femoral Head and Degenerative Hip Joint Disease, this trial is actively recruiting participants. The trial is conducted by Dedienne Sante S.A.S. and has accumulated 8 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2022 – ~Dec 2022 · 9 months · monthly snapshotRecruiting~Dec 2022 – ~Apr 2023 · 4 months · monthly snapshot~Apr 2023 – ~Jul 2023 · 3 months · monthly snapshot~Jul 2023 – ~Feb 2024 · 7 months · monthly snapshotRecruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotRecruiting~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

8 versions recorded
  1. Sep 2025 — Present [monthly]

    Recruiting

  2. Sep 2024 — Sep 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Feb 2024 — Jul 2024 [monthly]

    Recruiting

  5. Jul 2023 — Feb 2024 [monthly]

    Recruiting

Show 3 earlier versions
  1. Apr 2023 — Jul 2023 [monthly]

    Recruiting

  2. Dec 2022 — Apr 2023 [monthly]

    Recruiting

  3. Mar 2022 — Dec 2022 [monthly]

    Recruiting

    First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dedienne Sante S.A.S.
  • EVAMED
Data source: Dedienne Sante S.A.S.

For direct contact, visit the study record on ClinicalTrials.gov .